{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:10:42Z","timestamp":1790604642262,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["#174530"],"award-info":[{"award-number":["#174530"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"C3.ai Digital Transformation Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Care Manag Sci"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10729-021-09545-5","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T08:02:46Z","timestamp":1615795366000},"page":"339-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Personalized prescription of ACEI\/ARBs for hypertensive COVID-19 patients"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1985-1003","authenticated-orcid":false,"given":"Dimitris","family":"Bertsimas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Borenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mingardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Nohadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agni","family":"Orfanoudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartolomeo","family":"Stellato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Wiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Varelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Macaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n J. N\u00fa\u00f1ez","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"issue":"434","key":"9545_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/01621459.1996.10476902","volume":"91","author":"JD Angrist","year":"1996","unstructured":"Angrist JD, Imbens GW, Rubin DB (1996) Identification of causal effects using instrumental variables. Journal of the American Statistical Association 91(434):444\u2013455. http:\/\/www.jstor.org\/stable\/2291629","journal-title":"Journal of the American Statistical Association"},{"issue":"27","key":"9545_CR2","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1073\/pnas.1510489113","volume":"113","author":"S Athey","year":"2016","unstructured":"Athey S, Imbens G (2016) Recursive partitioning for heterogeneous causal effects. Proceedings of the National Academy of Sciences 113(27):7353\u20137360 . https:\/\/doi.org\/10.1073\/pnas.1510489113. https:\/\/www.pnas.org\/content\/113\/27\/7353. https:\/\/www.pnas.org\/content\/113\/27\/7353.full.pdf","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9545_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"P Austin","year":"2011","unstructured":"Austin P (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research 46:399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786","journal-title":"Multivariate Behavioral Research"},{"key":"9545_CR4","doi-asserted-by":"publisher","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, F\u00e3tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC (2011) Remdesivir for the Treatment of Covid-19 Final Report. N Engl J Med 383:1813-1826. https:\/\/doi.org\/10.1056\/NEJMoa2007764","DOI":"10.1056\/NEJMoa2007764"},{"issue":"4","key":"9545_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1080\/10618600.2020.1753532","volume":"29","author":"M Bennett","year":"2020","unstructured":"Bennett M, Vielma JP, Zubizarreta JR (2020) Building representative matched samples with multi-valued treatments in large observational studies. J Comput Graph Stat 29(4):744\u2013757. https:\/\/doi.org\/10.1080\/10618600.2020.1753532","journal-title":"J Comput Graph Stat"},{"issue":"7","key":"9545_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10994-017-5633-9","volume":"106","author":"D Bertsimas","year":"2017","unstructured":"Bertsimas D, Dunn J (2017) Optimal classification trees. Mach Learn 106(7):1039\u20131082. https:\/\/doi.org\/10.1007\/s10994-017-5633-9","journal-title":"Mach Learn"},{"issue":"2","key":"9545_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2337\/dc16-0826","volume":"40","author":"D Bertsimas","year":"2017","unstructured":"Bertsimas D, Kallus N, Weinstein AM, Zhuo YD (2017) Personalized diabetes management using electronic medical records. Diabetes Care 40(2):210\u2013217. https:\/\/doi.org\/10.2337\/dc16-0826. https:\/\/care.diabetesjournals.org\/content\/40\/2\/210. https:\/\/care.diabetesjournals.org\/content\/40\/2\/210.full.pdf","journal-title":"Diabetes Care"},{"issue":"2","key":"9545_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1287\/ijoo.2018.0005","volume":"1","author":"D Bertsimas","year":"2019","unstructured":"Bertsimas D, Dunn J, Mundru N (2019) Optimal prescriptive trees. INFORMS Journal on Optimization 1(2):164\u2013183. https:\/\/doi.org\/10.1287\/ijoo.2018.0005","journal-title":"INFORMS Journal on Optimization"},{"key":"9545_CR9","doi-asserted-by":"crossref","unstructured":"Bertsimas D, Borentein A, Dauvin A, Orfanoudaki A (2020) Ensemble Machine Learning for Personalized Antihypertensive Treatment. Naval Research Logistics (Under Review)","DOI":"10.1002\/nav.22040"},{"key":"9545_CR10","doi-asserted-by":"publisher","unstructured":"Bertsimas D, Orfanoudaki A, Weiner R (2020) Personalized treatment for coronary artery disease patients: a machine learning approach. Health Care Management Science. https:\/\/doi.org\/10.1007\/s10729-020-09522-4","DOI":"10.1007\/s10729-020-09522-4"},{"issue":"6","key":"9545_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMoa2016638","volume":"383","author":"DR Boulware","year":"2020","unstructured":"Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH (2020) A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N Engl J Med 383(6):517\u2013525. https:\/\/doi.org\/10.1056\/NEJMoa2016638","journal-title":"N Engl J Med"},{"issue":"1","key":"9545_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L (2001) Random forests. Machine Learning 45(1):5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324","journal-title":"Machine Learning"},{"key":"9545_CR13","doi-asserted-by":"publisher","unstructured":"Breiman L, Friedman J, Stone CJ, Olshen RA (1984) Classification and regression trees. CRC Press. https:\/\/doi.org\/10.1201\/9781315139470","DOI":"10.1201\/9781315139470"},{"key":"9545_CR14","doi-asserted-by":"publisher","unstructured":"Buuren SV, Groothuis-Oudshoorn K (2010) Mice: Multivariate Imputation by Chained Equations in R. J Stat Softw 45:2\u201320. https:\/\/doi.org\/10.18637\/jss.v045.i03","DOI":"10.18637\/jss.v045.i03"},{"key":"9545_CR15","doi-asserted-by":"publisher","unstructured":"Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T, Tang C, Sang L, Liu J, Ni Z, Hu Y, Liu L, Shan H, Lei C, Peng Y, Wei L, Liu Y, Hu Y, Peng P, Wang J, Liu J, Chen Z, Li G, Zheng Z, Qiu S, Luo J, Ye C, Zhu S, Liu X, Cheng L, Ye F, Zheng J, Zhang N, Li Y, He J, Li S, Zhong N (2020) Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest 158:97\u2013105. https:\/\/doi.org\/10.1016\/j.chest.2020.04.010","DOI":"10.1016\/j.chest.2020.04.010"},{"key":"9545_CR16","doi-asserted-by":"publisher","unstructured":"Chen T, Guestrin C (2016) Xgboost: a scalable tree boosting system. In: Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining, pp 785\u2013794. https:\/\/doi.org\/10.1145\/2939672.2939785","DOI":"10.1145\/2939672.2939785"},{"key":"9545_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.copbio.2019.03.004","volume":"58","author":"D Cirillo","year":"2019","unstructured":"Cirillo D, Valencia A (2019) Big data analytics for personalized medicine. Current Opinion in Biotechnology 58:161\u2013167. https:\/\/doi.org\/10.1016\/j.copbio.2019.03.004","journal-title":"Current Opinion in Biotechnology"},{"key":"9545_CR18","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","volume":"2019","author":"KJ Clerkin","year":"2020","unstructured":"Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani LR, Schwartz A, Uriel N (2020) COVID-19 and cardiovascular disease. Circulation 2019:1648\u20131655. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046941","journal-title":"Circulation"},{"issue":"5","key":"9545_CR19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/HJH.0000000000002450","volume":"38","author":"M Esler","year":"2020","unstructured":"Esler M, Esler D (2020) Can angiotensin receptor-blocking drugs perhaps be harmful in the covid-19 pandemic? Journal of Hypertension 38(5):781\u2013782. https:\/\/doi.org\/10.1097\/HJH.0000000000002450","journal-title":"Journal of Hypertension"},{"issue":"8","key":"9545_CR20","first-page":"2544","volume":"38","author":"ML Feldstein","year":"1978","unstructured":"Feldstein ML, Savlov ED, Hilf R (1978) A statistical model for predicting response of breast cancer patients to cytotoxic chemotherapy. Cancer Res 38(8):2544\u20132548","journal-title":"Cancer Res"},{"key":"9545_CR21","doi-asserted-by":"publisher","unstructured":"Gautret P, Lagier JC, Parola P, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 56:105949. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105949","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"issue":"25","key":"9545_CR22","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","volume":"382","author":"J Geleris","year":"2020","unstructured":"Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson DK, Kubin C, Barr RG, Sobieszczyk ME, Schluger NW (2020) Observational study of hydroxychloroquine in hospitalized patients with covid-19. N Engl J Med 382(25):2411\u20132418. https:\/\/doi.org\/10.1056\/NEJMoa2012410","journal-title":"N Engl J Med"},{"key":"9545_CR23","doi-asserted-by":"publisher","unstructured":"Gil IJN, Estrada V, Fern\u00e1ndez-P\u00e9rez C, Feltes G, Vedia O, Vergara-Uzcategui CE, Moreno V, Cerrato E, D\u2019Ascenzo F, Raposeiras-Roubin S, et al. (2020) Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design. Contemp Clin Trials Commun 20:100654. https:\/\/doi.org\/10.1016\/j.conctc.2020.100654","DOI":"10.1016\/j.conctc.2020.100654"},{"issue":"24","key":"9545_CR24","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","volume":"382","author":"J Grein","year":"2020","unstructured":"Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, et al. (2020) Compassionate use of remdesivir for patients with severe covid-19. N Engl J Med 382(24):2327\u20132336. https:\/\/doi.org\/10.1056\/NEJMoa2007016","journal-title":"N Engl J Med"},{"key":"9545_CR25","doi-asserted-by":"publisher","unstructured":"Group RC (2020) Dexamethasone in hospitalized patients with covid-19\u2014preliminary report. New England Journal of Medicine. https:\/\/doi.org\/10.1056\/NEJMoa2021436","DOI":"10.1056\/NEJMoa2021436"},{"issue":"4","key":"9545_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMp1006304","volume":"363","author":"MA Hamburg","year":"2010","unstructured":"Hamburg MA, Collins FS (2010) The path to personalized medicine. N Engl J Med 363 (4):301\u2013304. https:\/\/doi.org\/10.1056\/NEJMp1006304","journal-title":"N Engl J Med"},{"key":"9545_CR27","doi-asserted-by":"publisher","unstructured":"Hastie T, Tibshirani R, Friedman J (2009) The elements of statistical learning: data mining, inference, and prediction. Springer Science & Business Media. https:\/\/doi.org\/10.1007\/978-0-387-84858-7","DOI":"10.1007\/978-0-387-84858-7"},{"issue":"5","key":"9545_CR28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/ajh.2009.33","volume":"22","author":"SR Heckbert","year":"2009","unstructured":"Heckbert SR, Wiggins KL, Glazer NL, Dublin S, Psaty BM, Smith NL, Longstreth W, Lumley T (2009) Antihypertensive treatment with ace inhibitors or \u03b2-blockers and risk of incident atrial fibrillation in a general hypertensive population. American Journal of Hypertension 22(5):538\u2013544. https:\/\/doi.org\/10.1038\/ajh.2009.33","journal-title":"American Journal of Hypertension"},{"key":"9545_CR29","doi-asserted-by":"publisher","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. (2020) Sars-cov-2 cell entry depends on ace2 and tmprss2 and is blocked by a clinically proven protease inhibitor. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"9545_CR30","doi-asserted-by":"publisher","unstructured":"Imbens GW, Rubin DB (2019) Causal inference: for statistics, social, and biomedical sciences: an introduction. Cambridge University Press. https:\/\/doi.org\/10.1017\/CBO9781139025751","DOI":"10.1017\/CBO9781139025751"},{"key":"9545_CR31","unstructured":"Interpretable AIL (2020) Interpretable ai documentation. https:\/\/www.interpretable.ai"},{"issue":"10","key":"9545_CR32","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jama.2015.7725","volume":"314","author":"MJ Joyner","year":"2015","unstructured":"Joyner MJ, Paneth N (2015) Seven questions for personalized medicine. Jama 314(10):999\u20131000. https:\/\/doi.org\/10.1001\/jama.2015.7725","journal-title":"Jama"},{"key":"9545_CR33","unstructured":"Kallus N (2016) Recursive partitioning for personalization using observational data. 1608.08925"},{"key":"9545_CR34","doi-asserted-by":"publisher","unstructured":"Li J, Wang X, Chen J, Zhang H, Deng A (2020) Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (covid-19) infection in Wuhan, China. JAMA Cardiology. https:\/\/doi.org\/10.1001\/jamacardio.2020.1624","DOI":"10.1001\/jamacardio.2020.1624"},{"key":"9545_CR35","doi-asserted-by":"publisher","unstructured":"Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang Z, et al. (2020) Risk factors for severity and mortality in adult covid-19 inpatients in wuhan. Journal of Allergy and Clinical Immunology. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.006","DOI":"10.1016\/j.jaci.2020.04.006"},{"key":"9545_CR36","doi-asserted-by":"publisher","unstructured":"Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HH, Luo M, Chen L, Zhao Y (2020) Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with covid-19. Journal of Infection. https:\/\/doi.org\/10.1016\/j.jinf.2020.04.002","DOI":"10.1016\/j.jinf.2020.04.002"},{"key":"9545_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ahj.2020.05.002","volume":"226","author":"RD Lopes","year":"2020","unstructured":"Lopes RD, Macedo AVS, de Barros e Silva PGM, Moll-Bernardes RJ, Feldman A, D\u2019Andr\u00e9a Saba, Arruda G, de Souza AS, de Albuquerque DC, Mazza L, Santos MF, Salvador NZ, Gibson CM, Granger CB, Alexander JH, de Souza OF (2020) Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\u2013The BRACE CORONA Trial: BRACE CO. American Heart Journal 226:49\u201359. https:\/\/doi.org\/10.1016\/j.ahj.2020.05.002","journal-title":"American Heart Journal"},{"key":"9545_CR38","unstructured":"Lundberg S, Lee SI (2017) A unified approach to interpreting model predictions. In: Guyon I, Luxburg UV, Bengio S, Wallach H, Fergus R, Vishwanathan S, Garnett R (eds) Advances in neural information processing systems 30, Curran Associates, Inc, pp 4765\u20134774. http:\/\/papers.nips.cc\/paper\/7062-a-unified-approach-to-interpreting-model-predictions.pdf"},{"issue":"1","key":"9545_CR39","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"S Lundberg","year":"2020","unstructured":"Lundberg S, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, Katz R, Himmelfarb J, Bansal N, Lee SI (2020) From local explanations to global understanding with explainable AI for trees. Nature Machine Intelligence 2(1):2522\u20135839. https:\/\/doi.org\/10.1038\/s42256-019-0138-9","journal-title":"Nature Machine Intelligence"},{"key":"9545_CR40","doi-asserted-by":"publisher","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G (2020) Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of covid-19. New England Journal of Medicine. https:\/\/doi.org\/10.1056\/NEJMoa2006923","DOI":"10.1056\/NEJMoa2006923"},{"issue":"9","key":"9545_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","volume":"17","author":"M Nishiga","year":"2020","unstructured":"Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC (2020) COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 17(9):543\u2013558. https:\/\/doi.org\/10.1038\/s41569-020-0413-9","journal-title":"Nat Rev Cardiol"},{"key":"9545_CR42","unstructured":"Organization WH (2020) COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers: scientific brief, 7 May 2020. Technical documents"},{"key":"9545_CR43","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R, Dubourg V, et al. (2011) Scikit-learn: machine learning in python. J Mach Learn Res 12:2825\u20132830","journal-title":"J Mach Learn Res"},{"issue":"2","key":"9545_CR44","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1214\/10-AOS864","volume":"39","author":"M Qian","year":"2011","unstructured":"Qian M, Murphy SA (2011) Performance guarantees for individualized treatment rules. Ann Statist 39(2):1180\u20131210. https:\/\/doi.org\/10.1214\/10-AOS864","journal-title":"Ann Statist"},{"issue":"14","key":"9545_CR45","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I (2019) Machine learning in medicine. N Engl J Med 380 (14):1347\u20131358. https:\/\/doi.org\/10.1056\/NEJMra1814259","journal-title":"N Engl J Med"},{"issue":"25","key":"9545_CR46","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S, Katz SD, Fishman GI, Kunichoff D, Chen Y, Ogedegbe G, Hochman JS (2020) Renin-angiotensin-aldosterone system inhibitors and risk of covid-19. N Engl J Med 382(25):2441\u20132448. https:\/\/doi.org\/10.1056\/NEJMoa2008975","journal-title":"N Engl J Med"},{"issue":"40","key":"9545_CR47","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/eurheartj\/ehv161","volume":"36","author":"GMC Rosano","year":"2015","unstructured":"Rosano GMC, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, Drexel H, Patak A, Torp-Pedersen C, Kjeldsen KP, Tamargo J (2015) Gender differences in the effect of cardiovascular drugs: a position document of the working group on pharmacology and drug therapy of the ESC. Eur Heart J 36(40):2677\u20132680. https:\/\/doi.org\/10.1093\/eurheartj\/ehv161","journal-title":"Eur Heart J"},{"key":"9545_CR48","doi-asserted-by":"publisher","unstructured":"Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 109:102433. https:\/\/doi.org\/10.1016\/j.jaut.2020.102433","DOI":"10.1016\/j.jaut.2020.102433"},{"key":"9545_CR49","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46:846\u2013848. https:\/\/doi.org\/10.1007\/s00134-020-05991-x","journal-title":"Intensive Care Med"},{"issue":"5","key":"9545_CR50","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1037\/h0037350","volume":"66","author":"DB Rubin","year":"1974","unstructured":"Rubin DB (1974) Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol 66(5):688\u2013701. https:\/\/doi.org\/10.1037\/h0037350","journal-title":"J Educ Psychol"},{"issue":"4","key":"9545_CR51","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1214\/ss\/1177012032","volume":"5","author":"DB Rubin","year":"1990","unstructured":"Rubin DB (1990) Comment: Neyman (1923) and causal inference in experiments and observational studies. Statist Sci 5(4):472\u2013480. https:\/\/doi.org\/10.1214\/ss\/1177012032","journal-title":"Statist Sci"},{"issue":"32","key":"9545_CR52","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1093\/eurheartj\/ehaa509","volume":"41","author":"F Sanchis-Gomar","year":"2020","unstructured":"Sanchis-Gomar F, Perez-Quilis C, Lavie CJ (2020) Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients? European Heart Journal 41 (32):3092\u20133093. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa509. https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/32\/3092\/33873098\/ehaa509.pdf","journal-title":"European Heart Journal"},{"issue":"18","key":"9545_CR53","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.2020.6019","volume":"323","author":"JM Sanders","year":"2020","unstructured":"Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic treatments for coronavirus disease 2019 (covid-19): a review. Jama 323(18):1824\u20131836. https:\/\/doi.org\/10.1001\/jama.2020.6019","journal-title":"Jama"},{"issue":"5","key":"9545_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/ajh\/hpaa057","volume":"33","author":"EL Schiffrin","year":"2020","unstructured":"Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC (2020) Hypertension and COVID-19. American Journal of Hypertension 33(5):373\u2013374. https:\/\/doi.org\/10.1093\/ajh\/hpaa057. https:\/\/academic.oup.com\/ajh\/article-pdf\/33\/5\/373\/33166270\/hpaa057.pdf","journal-title":"American Journal of Hypertension"},{"issue":"2","key":"9545_CR55","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","volume":"91","author":"J Stoehlmacher","year":"2004","unstructured":"Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, Lenz HJ (2004) A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 91(2):344\u2013354. https:\/\/doi.org\/10.1038\/sj.bjc.6601975","journal-title":"Br J Cancer"},{"issue":"523","key":"9545_CR56","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/01621459.2017.1319839","volume":"113","author":"S Wager","year":"2018","unstructured":"Wager S, Athey S (2018) Estimation and inference of heterogeneous treatment effects using random forests. J Am Stat Assoc 113(523):1228\u20131242. https:\/\/doi.org\/10.1080\/01621459.2017.1319839","journal-title":"J Am Stat Assoc"},{"key":"9545_CR57","doi-asserted-by":"publisher","unstructured":"Wang JJ, Edin ML, Zeldin DC, Li C, Wang DW, Chen C (2020) Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities. Pharmacol Ther 215:107628. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107628","DOI":"10.1016\/j.pharmthera.2020.107628"},{"key":"9545_CR58","doi-asserted-by":"publisher","unstructured":"Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, et al. (2020) Remdesivir in adults with severe covid-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(20)31022-9","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"9545_CR59","unstructured":"WHO (2020) Who coronavirus disease (covid-19) dashboard. https:\/\/covid19.who.int\/. Accessed 17 Sep 2020"},{"key":"9545_CR60","doi-asserted-by":"publisher","unstructured":"Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y (2020) The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 55:105955. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105955","DOI":"10.1016\/j.ijantimicag.2020.105955"},{"key":"9545_CR61","unstructured":"Zhang H (2004) The optimality of naive bayes, 2004. Am5erican Association for Artificial Intelligence (www aaai org)"},{"issue":"12","key":"9545_CR62","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, Liu YM, Zhao YC, Huang X, Lin L, Xia M, Chen MM, Cheng X, Zhang X, Guo D, Peng Y, Ji YX, Chen J, She ZG, Wang Y, Xu Q, Tan R, Wang H, Lin J, Luo P, Fu S, Cai H, Ye P, Xiao B, Mao W, Liu L, Yan Y, Liu M, Chen M, Zhang XJ, Wang X, Touyz RM, Xia J, Zhang BH, Huang X, Yuan Y, Loomba R, Liu PP, Li H (2020) Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with covid-19. Circulation Research 126(12):1671\u20131681. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317134. https:\/\/www.ahajournals.org\/doi\/abs\/10.1161\/CIRCRESAHA.120.317134","journal-title":"Circulation Research"},{"key":"9545_CR63","unstructured":"Zubizarreta JR, Kilcioglu C, Vielma JP (2018) designmatch: matched samples that are balanced and representative by design. https:\/\/CRAN.R-project.org\/package=designmatch. r package version 0.3.1"}],"container-title":["Health Care Management Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10729-021-09545-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10729-021-09545-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10729-021-09545-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:23:25Z","timestamp":1671614605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10729-021-09545-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["9545"],"URL":"https:\/\/doi.org\/10.1007\/s10729-021-09545-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.30.20223594","asserted-by":"object"}]},"ISSN":["1386-9620","1572-9389"],"issn-type":[{"value":"1386-9620","type":"print"},{"value":"1572-9389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"30 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All independent organizations and the Massachusetts Institute of Technology institutional review boards approved this protocol as minimal-risk research using data collected for standard clinical practice and waived the requirement for informed consent. The survey was anonymous and confidentiality of information was assured.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no competing interests to declare that may be relevant to the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}